VERA THERAPEUTICS INC (VERA)
US92337R1014 - Common Stock
ChartMill assigns a Buy % Consensus number of 84% to VERA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 58.85. This target is 46.37% above the current price.
VERA was analyzed by 16 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about VERA.
In the previous month the buy percentage consensus was at a similar level.
VERA was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-10-03 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-10-01 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-09-23 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-09-16 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-09-09 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-09-06 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-09-03 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-08-13 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-05-31 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-05-10 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2024-04-05 | Guggenheim | Reiterate | Buy -> Buy |
| 2024-03-27 | Guggenheim | Maintains | Buy -> Buy |
| 2024-03-21 | Wedbush | Maintains | Neutral -> Neutral |
| 2024-01-26 | Wedbush | Maintains | Neutral -> Neutral |
| 2024-01-26 | Raymond James | Upgrade | Outperform -> Strong Buy |
| 2024-01-25 | Oppenheimer | Initiate | Outperform |
| 2024-01-08 | Cantor Fitzgerald | Initiate | Overweight |
| 2023-12-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-12-18 | Raymond James | Initiate | Outperform |
| 2023-11-30 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-11-10 | Jefferies | Upgrade | Hold -> Buy |
| 2023-09-26 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-16 | Guggenheim | Initiate | Buy |
| 2023-08-11 | Wedbush | Maintains | Neutral -> Neutral |
| 2023-06-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-12 | Wedbush | Maintains | Neutral -> Neutral |
| 2023-05-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-04-12 | JP Morgan | Maintains | Overweight |
| 2023-03-29 | HC Wainwright & Co. | Maintains | Buy |
| 2023-01-04 | Wedbush | Downgrade | Outperform -> Neutral |